Newbury Pharmaceuticals AB Net Asset Momentum
Newbury Pharmaceuticals AB net asset momentum. Newbury Pharmaceuticals AB (NEWBRY) recorded a net asset momentum of 5.1% as of August 2024, with net assets of Skr51.92 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Newbury Pharmaceuticals AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Newbury Pharmaceuticals AB (2021–2024)
Net asset momentum of Newbury Pharmaceuticals AB from 2021 to 2024. This chart tracks Newbury Pharmaceuticals AB's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +5.1%, with net assets of Skr51.92 Million SEK as of August 2024. See NEWBRY net asset value for net asset value and shareholders' equity analysis.
Newbury Pharmaceuticals AB Net Asset Momentum by Year (2021–2024)
Newbury Pharmaceuticals AB net asset momentum by year from 2021 to 2024. The table below shows the complete annual net asset history for Newbury Pharmaceuticals AB from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of Newbury Pharmaceuticals AB.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr51.92 Million | Skr90.87 Million | Skr38.95 Million | ▲ +5.1% |
| 2023 | Skr49.38 Million | Skr72.92 Million | Skr23.54 Million | ▼ -28.2% |
| 2022 | Skr68.77 Million | Skr86.91 Million | Skr18.14 Million | ▲ +78.8% |
| 2021 | Skr38.47 Million | Skr42.81 Million | Skr4.34 Million | — |